Cargando…
Translating Metabolic Reprogramming into New Targets for Kidney Cancer
In the age of bioinformatics and with the advent of high-powered computation over the past decade or so the landscape of biomedical research has become radically altered. Whereas a generation ago, investigators would study their “favorite” protein or gene and exhaustively catalog the role of this co...
Autores principales: | Abu Aboud, Omran, Weiss, Robert H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179106/ https://www.ncbi.nlm.nih.gov/pubmed/30334010 http://dx.doi.org/10.3233/KCA-170014 |
Ejemplares similares
-
Inhibition of PPARα Induces Cell Cycle Arrest and Apoptosis, and Synergizes with Glycolysis Inhibition in Kidney Cancer Cells
por: Abu Aboud, Omran, et al.
Publicado: (2013) -
Energy metabolism pathways in breast cancer progression: The reprogramming, crosstalk, and potential therapeutic targets
por: Zheng, Xuewei, et al.
Publicado: (2022) -
Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer
por: Trott, Josephine F., et al.
Publicado: (2016) -
Making cancer fat: reprogramming of lipid metabolism by CD147 in hepatocellular carcinoma
por: Ju, Hye-Lim, et al.
Publicado: (2016) -
Commentary on ‘Metabolic reprogramming‐associated genes predict overall survival for rectal cancer’
por: Shen, Ruihuan
Publicado: (2020)